February 2025
Includes: Testosterone Therapy May Not Up Recurrence, Additional prostate cancer treatment may adversely affect quality of life, Novartis: A New Treatment for PC, and more.
THE PATHFINDER AWARD FOR 2025 POSTHUMOUSLY HONOURS RON GORHAM WHO SERVED PROSTAID FOR 30 YEARS
Includes: Testosterone Therapy May Not Up Recurrence, Additional prostate cancer treatment may adversely affect quality of life, Novartis: A New Treatment for PC, and more.